The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study
Christian Waldherr(University Hospital of Basel), Misha Pless, Helmut R. Maëcke(Hospital Base), Andreas Haldemann(Institute of Oncology Research), Jan Mueller‐Brand
Cited by 394
Abstract
Related Papers
No related papers found
Powered by citation graph analysis